AZD0292, Placebo for AZD0292
D7700C00003
Phase 2 small_molecule active
Quick answer
AZD0292, Placebo for AZD0292 for Bronchiectasis with chronic pseudomonas aeruginosa colonization is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Bronchiectasis with chronic pseudomonas aeruginosa colonization
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active